FRESENIUS MEDICAL CARE HOLDINGS INC /NY/

Fresenius Medical Care Holdings Inc /NY/ stands as a global leader within SIC’s medical instruments and supplies universe, developing dialysis machines, consumables, and tailored chronic kidney care platforms that underpin its core services for hospital systems, nephrology clinics, and large employer-sponsored managed care programs; serving the rapidly aging and increasingly chronic disease-afflicted patient population, the company relies on a sprawling clinical network and partner labs to maintain quality and supply continuity, yet it must manage material risks such as shifting reimbursement policies, pandemic-driven staffing shortages, and intensive healthcare regulation from CMS and international authorities, all while keeping a close eye on licensing, cytotoxic waste, and patient privacy compliance in markets spanning North America to Europe and Asia, with the latest filing noted as unknown; investors tracking the company through CIK 42872 can view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025